BACE1 and Alzheimer disease: PERK insufficiency has been shown to effectively inhibit β-secretase enzyme BACE1 expression and concomitant Aβ peptides and plaque burden, resulting in the restoration of memory deficits and cholinergic neurodegeneration in five familial AD (5XFAD) mouse models (206).